Please note: AABB reserves the right to make updates to this program
Live Program Date: Thursday, July 26, 2018 -
Master Program Number: 18EL-348 (see program format numbers below under Registration)
Educational Track: Cellular Therapies
Intended Audience: Hospitals, Hospital Blood Banks, Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Physicians, Research Scientist, Resident/Fellow, Scientists, Students (MD, MT, SBB), Technologist
Teaching Level: Intermediate
Director/ Moderator: Deborah A. Sesok-Pizzini, MD, MBA, CQA(ASQ)CMQ/OE, Chief, Blood Bank and Transfusion Medicine, The Children’s Hospital of Philadelphia, Philadelphia, PA
Speaker: Jennifer Heimall, MD, Attending Physician, Division of Allergy and Immunology Service, Children's Hospital of Philadelphia, Philadelphia, PA
After participating in this educational activity, participants should be able to:
- Discuss the development of gene therapy in SCID patients and its potential to become a more commonly used treatment.
- Identify other current treatment options for SCID including HCT and enzyme replacement.
- Discuss the need for ongoing studies to evaluate the long-term effects of current therapy alternatives.
This program will explore the use of gene therapy for severe combined immunodeficiency syndrome and discuss up to date advances in the field. Other therapies including (Hematopoietic stem cell transplantation) HCT therapy and enzyme replacement will also be discussed. The speaker will also address ongoing studies that are needed to reduce the late effects beyond survival with the current treatment options.
| || ||
|Single Viewer: On-Demand||
|Group Viewing: On-Demand||
Continuing Education Credit
AABB designates both the live and on-demand version of this eCast each eligible for 1 continuing education credit/contact hour for Physicians, General Participation, California Nurse, California Lab Personnel and Florida Lab Personnel. The number and type of credits awarded for this program (both live and on-demand) was determined by the program duration. For more information on each credit type please visit our Continuing Education Credits webpage.
Disclosures for the planners of this event can be found here. Disclosures for the program faculty are provided at the beginning of the program.
Dr. Jennifer Heimall is a graduate of UMDNJ-New Jersey Medical School where she also completed residencies in Internal Medicine and Pediatrics. She then went on to complete a clinical and research fellowship in Allergy and Immunology at the National Institute of Health. She is an Attending Physician in the Division of Allergy and Immunology at CHOP.
Dr. Heimall’s expertise include Hyper IgE syndromes, post-transplant immune reconstitution, recurrent staphylococcal infections and atopic dermatitis, and appropriate transition of care from pediatric to adult physicians. She is the recent author of a paper, “Long Term Outcomes of Severe Combined Immunodeficiency: Therapy Implications” published in the
Expert Review of Clinical Immunology.